Inventor

MILLS SANDER G

US84 patents

⚠️ This page may combine multiple inventors who share the name “MILLS SANDER G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MILLS SANDER G

MERCK & CO INC

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine compounds are prodrugs useful as tachykinin receptor antagonists

Pyrrolidine and piperidine modulators of chemokine receptor activity

Spiro-substituted azacycles as modulators of chemokine receptor activity

Src kinase inhibitor compounds

SRC kinase inhibitor compounds

SRC kinase inhibitor compounds

3,3-disubstituted piperidines as modulators of chemokine receptor activity

Morpholine compounds are prodrugs useful as tachykinin receptor antagonists

Treatment of migraine with morpholine tachykinin receptor antagonists

Process for preparing morpholine tachykinin receptor antagonists

Treatment of emesis with morpholine tachykinin receptor antagonists

Alicyclic compounds as tachykinin receptor antagonists

N,N-diacylpiperazines

Spiro-substituted azacycles as modulators of chemokine receptor activity

Substituted β-alanine derivatives as cell adhesion inhibitors

Spiro-substituted azacycles as neurokinin antagonists

Cycloalkyl tachykinin receptor antagonists

N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Hydroisoindoline tachykinin receptor antagonists

Hydroisoindoline tachykinin receptor antagonists

Cyclopentyl modulators of chemokine receptor activity

Modulators of CCR5 chemokine receptor activity

Pyrrolidine modulators of chemokine receptor activity

Biarylalkanoic acids as cell adhesion inhibitors

Pyrrolidine modulators of chemokine receptor activity

Sulfonamides as cell adhesion inhibitors

Cyclic amine modulators of chemokine receptor activity

Cyclic amine modulations of chemokine receptor activity

Spiro-substituted azacycles as tachykinin receptor antagonists

Substituted aryl piperazines as neurokinin antagonists

N,N-diacylpiperazine tachykinin antagonists

Aminoalkylphosphonates and related compounds as Edg receptor agonists

Cyclopentyl modulators of chemokine receptor activity

Edg receptor agonists

1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists

Cyclopentyl modulators of chemokine receptor activity

N-acylpiperidine tachykinin antagonists

Substituted azetidinones as anti-inflammatory and antidegenerative agents

1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists

Pyrrolidine modulators of chemokine receptor activity

Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity

Cyclopentyl modulators of chemokine receptor activity

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK SHARP & DOHME

Hydroisoindoline tachykinin receptor antagonists

Prodrugs of oxazolidinone CETP inhibitors

Hydroisoindoline tachykinin receptor antagonists

DEVITA ROBERT J

Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists